Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05347602 · ClinicalTrials.gov registry record · NA

Gold Factor on Knee Joint Health and Function

A NA study of Rheumatoid Arthritis and Knee Osteoarthritis, sponsored by 4Life Research.

Completed
Registry status
NA
Development phase
51
Enrollment target
1
Study location

NCT05347602 is a NA study of Rheumatoid Arthritis and Knee Osteoarthritis that has completed, run by 4Life Research. The registered enrollment target is 51 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05347602, a NA study of Rheumatoid Arthritis and Knee Osteoarthritis, has completed, sponsored by 4Life Research.

COMPLETED
Registry status
NA
Development phase
51 participants
Enrollment target
1
Study location

Study Summary

The purpose of this clinical study was to determine whether gold nanoparticles (AuNP) supplement holds clinical value in improving joint health, function, and quality of life for arthritis patients.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Gold Factor (Gold Nanoparticles, AuNPs)

Study Locations (1)

Missouri

  • Professional Athletic Orthopedics - St Louis

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2020-08-03
Est. Completion 2020-12-30
Phase NA

Sponsor

4Life Research

7 total trials

What the Registry Record Tells You About NCT05347602

The ClinicalTrials.gov registry entry for NCT05347602 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (99% lower). The listed sponsor is 4Life Research, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05347602 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT05347602 about?

NCT05347602 is a clinical study titled "Gold Factor on Knee Joint Health and Function". The purpose of this clinical study was to determine whether gold nanoparticles (AuNP) supplement holds clinical value in improving joint health, function, and quality of life for arthritis patients.

What is the current status of trial NCT05347602?

This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2020-08-03. Estimated completion is 2020-12-30.

What conditions does trial NCT05347602 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis, Knee Osteoarthritis, Knee Pain Chronic, Knee Arthritis, Knee Discomfort.

What interventions are being tested in trial NCT05347602?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Gold Factor (Gold Nanoparticles, AuNPs) (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05347602?

This trial is sponsored by 4Life Research, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05347602 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.